Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
37.01
-0.82
(-2.17%)
As of 12:39:14 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
699,971
699,971
333,324
362,614
400,804
Investing Cash Flow
-116,783
-116,783
-26,955
-524,414
-42,884
Financing Cash Flow
-628,808
-628,808
-546,052
586
-14,801
End Cash Position
217,374
217,374
262,994
502,677
663,891
Income Tax Paid Supplemental Data
170,482
170,482
185,658
127,870
12,960
Capital Expenditure
-66,185
-66,185
-162,969
-138,456
-64,225
Repurchase of Capital Stock
-652,033
-652,033
-550,378
--
--
Free Cash Flow
633,786
633,786
170,355
224,158
336,579
12/31/2021 - 4/19/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
50BA.F Bicycle Therapeutics plc
9.65
-4.46%
6XP.SG Xspray Pharma AB (publ)
2.8000
+1.08%
471A.F aTyr Pharma, Inc.
3.1400
-16.04%
GBM.F Inovio Pharmaceuticals, Inc.
1.7700
-5.85%
0M4.F Mersana Therapeutics, Inc.
0.5398
+27.64%
7UM.F Ultimovacs ASA
0.1670
-18.93%
22Z.F Zealand Pharma A/S
76.70
-5.37%
4YL.F Nanoform Finland Oyj
1.1600
+1.75%
5CV.F CureVac N.V.
2.8720
-0.97%
CARA Cara Therapeutics, Inc.
4.3300
-6.36%